A case series of upper limb ischemia due to thromboembolic complication of COVID-19

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a life-threatening multi-organ disease that has swept the globe. Patients with COVID-19 are at an increased risk of thromboembolic consequences involving both venous and arterial systems, according to growing evidence. Thromboembolic events in COVID more likely among patients hospitalized critical care unit, research. However, even ambulatory moderate cases infection, some have lately been documented comparable consequences. D-dimer fibrinogen levels lab can help determine likelihood developing thrombotic complications these patients. This case series discusses about three which had similar presentations coagulopathy upper limb arteries associated infection.